big data promises to expand the knowledge brought by clinical trials and lead
to safer therapies
authoritative source of medical information for almost 120 years, the MSD manuals are
now freely available online in Japanese
public were given a preview of therapies that promise to preserve the quality
of life of people well into old age
and clinical research is hampered by the
‘dissonant notes’ of poor efficacy systems and a lack of data standards, claim
researchers and policymakers. Fixing these problems can save lives.
positive stem cells could be used to treat a wide range of medical conditions
in clinical trials waste time and money, and cost lives. Global cooperation is
the only way to raise the bar.
TRI director Masanori Fukushima says considering disease mechanisms are the key to providing medicines to ease the journey into old age